Benazepril hydrochloride, >=98% (HPLC), solid

Benazepril hydrochloride, >=98% (HPLC), solid

Biochem/physiol Actions

Benazepril is a long-acting angiotensin converting enzyme (ACE) inhibitor.

Features and Benefits

This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

250, 500 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Quality Level InChI key InChI Manufacturer Form Assay Price Quantity
3573270 Benazepril hydrochloride, >=98% (HPLC), solid 100 VPSRQEHTHIMDQM-FKLPMGAJSA-N 1S/C24H28N2O5.ClH/c1-2-31-24(30)20(14-12-17-8-4-3-5-9-17)25-19-15-13-18-10-6-7-11-21(18)26(23(19)29)16-22(27)28;/h3-11,19-20,25H,2,12-16H2,1H3,(H,27,28);1H/t19 SIGMA-ALDRICH solid ≥98% (HPLC)
£959.68 (exc VAT) per 250MG
-
+
3573271 Benazepril hydrochloride, >=98% (HPLC), solid 100 VPSRQEHTHIMDQM-FKLPMGAJSA-N 1S/C24H28N2O5.ClH/c1-2-31-24(30)20(14-12-17-8-4-3-5-9-17)25-19-15-13-18-10-6-7-11-21(18)26(23(19)29)16-22(27)28;/h3-11,19-20,25H,2,12-16H2,1H3,(H,27,28);1H/t19 SIGMA-ALDRICH solid ≥98% (HPLC)
Click Add to Quote for price and delivery
-
+